Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000874015-22-000069
Filing Date
2022-02-02
Accepted
2022-02-02 19:26:02
Documents
1
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 7959
  Complete submission text file 0000874015-22-000069.txt   9420
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AVIDITY BIOSCIENCES, INC. 10975 N. TORREY PINES RD., SUITE 150 LA JOLLA CA 92037
Business Address
Baroldi Joseph (Reporting) CIK: 0001813775 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19125 | Film No.: 22585855